A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma

Lopez, Juanita Suzanne; Haefliger, Simon; Plummer, Ruth; Clement, Paul M.; Evans, Thomas R. Jeffry; Laubli, Heinz; Roth, Patrick; Kristeleit, Rebecca; Brazil, Lucy; Tabatabai, Ghazaleh; Wick, Antje; Wunderlich, Benjamin; Beebe, Kirk; Eisner, Joel Robert; Lane, Heidi; Engelhardt, Marc; Kaindl, Thomas; Hau, Peter; Hundsberger, Thomas; Steinbach, Joachim

dc.contributor.author	Tabatabai, Ghazaleh
dc.date.accessioned	2025-09-02T06:09:10Z
dc.date.available	2025-09-02T06:09:10Z
dc.date.issued	2025
dc.identifier.issn	2666-3791
dc.identifier.uri	http://hdl.handle.net/10900/169877
dc.language.iso	en	de_DE
dc.publisher	Cambridge : Cell Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.xcrm.2025.102165	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_00159
utue.personen.roh	Lopez, Juanita Suzanne
utue.personen.roh	Haefliger, Simon
utue.personen.roh	Plummer, Ruth
utue.personen.roh	Clement, Paul M.
utue.personen.roh	Evans, Thomas R. Jeffry
utue.personen.roh	Laubli, Heinz
utue.personen.roh	Roth, Patrick
utue.personen.roh	Kristeleit, Rebecca
utue.personen.roh	Brazil, Lucy
utue.personen.roh	Tabatabai, Ghazaleh
utue.personen.roh	Wick, Antje
utue.personen.roh	Wunderlich, Benjamin
utue.personen.roh	Beebe, Kirk
utue.personen.roh	Eisner, Joel Robert
utue.personen.roh	Lane, Heidi
utue.personen.roh	Engelhardt, Marc
utue.personen.roh	Kaindl, Thomas
utue.personen.roh	Hau, Peter
utue.personen.roh	Hundsberger, Thomas
utue.personen.roh	Steinbach, Joachim
dcterms.isPartOf.ZSTitelID	Cell Reports Medicine	de_DE
dcterms.isPartOf.ZS-Issue	Article 102165	de_DE
dcterms.isPartOf.ZS-Volume	6 (6)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE